Saturday, May 2, 2026

Sam Chun Dang Pharm Signs 100 Million USD Licensing Deal for Oral Generics of Rybelsus and Wegovy

Sam Chun Dang Pharm secures a U.S. licensing deal for generic diabetes and obesity medications, valued at $100 million.

North Korea Breaks COVID-19 Isolation, Invites Russian Tourists

North Korea is making moves to resume...

Half of Korean Doctors Using AI — But Who’s Accountable for Mistakes?

A survey reveals half of South Korean doctors use AI for medical tasks, but concerns about liability and patient disclosure persist.

Tag: hotel reviews

North KoreaKoreaKimMilitarySouth KoreaAImarketrelationsInternational

No posts to display

Top News

- Our Sponsors Ad -

Follow us

Cars

Tech

future

health

© Copyright by News1. All Rights Reserved.